Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 184.78

0.0%

Dec 8 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Flagrante Delictu who wrote (18527)	4/2/1998 3:11:00 PM
From: Henry Niman	Read Replies (1) of 32384

I don't think that GLX is a concern. I believe that LGND selected a TZD as well as an LDL modulator, and it's up to GLX to take the compounds through the clinic. LGND is relatively free of GLX, but I think that the applications that you are interested in would fall under the "metabolic disease" portion of the LLY deal, in which PPAR ligands as well as rexinoids are specifically mentioned.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next